Locations:
Search IconSearch
November 18, 2020/Neurosciences/Podcast

Virtual Neurological Care: From Telestroke to Today (Podcast)

The latest developments in telemedicine for subspecialty neuro care

The COVID-19 pandemic has fueled not only a surge in virtual outpatient visits, but also an increase in telemedicine for subspecialty neurological care. Consider the experience of Cleveland Clinic, which started a telestroke program about 10 years ago to bring acute stroke assessment to community hospitals that didn’t have consistent stroke coverage. Now Cleveland Clinic has expanded its use of telemedicine to neuro ICUs, neurophysiologic monitoring and more, notes stroke neurologist Zeshaun Khawaja, MD, MBA, who currently leads Cleveland Clinic’s telestroke program.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Dr. Khawaja shares the latest developments in virtual neurological care in the newest episode of Cleveland Clinic’s Neuro Pathways podcast. Among the topics discussed:

  • What’s been learned from the telestroke program and how it has evolved in the past decade
  • How telemedicine is increasing access, improving care and reducing neurologist burnout
  • The next neurological subspecialties positioned to benefit from telemedicine
  • Tips for neurologists preparing to offer virtual visits or expand telemedicine beyond outpatient settings

Click the player above to listen to the podcast now, or read on for a short edited excerpt. Check out more Neuro Pathways episodes at clevelandclinic.org/neuropodcast or wherever you get your podcasts.

Excerpt from the podcast

Podcast host Glen Stevens, DO, PhD: Our colleagues in neurophysiology have also started to adapt this technology. Tell me about that.

Dr. Khawaja: We’ve learned that virtual health is not just a face-to-face encounter. Imad Najm, MD, [Director of Cleveland Clinic’s Shor Epilepsy Center] and his epileptologist partners are really experts in this. They’ve been able to leverage their experience to offer a host of services, including direct patient evaluations — in both inpatient and outpatient settings — and patient management conferences. These are in-depth conferences that help determine if patients are candidates for highly specialized epilepsy surgery. The best thing is that they don’t require any patient travel, and don’t even require that patients come to Cleveland to have the surgery. Patients can benefit from these conferences and have surgery in their home community.

Advertisement

Dr. Najm’s group also has been able to create, run and manage entire epilepsy monitoring unit programs virtually, everything from design to training the technicians.

Dr. Stevens: What other areas of neurologic care do you see benefiting from telemedicine?

Dr. Khawaja: There’s so much potential. We’ve just scratched the surface with telestroke, with teleneurology. Now we’re seeing teleneurophysiology doing great things.

There are so many patients across our nation who don’t have access to specialists. Sometimes they’re forced to travel long distances just to see someone. This is not only disruptive to their normal routines, but it can be very costly — not just money spent on travel, but income lost due to being away from work.

As we continue to gain experience and experiment within virtual health, I’m really eager to see what comes next, particularly in the management of movement disorders, such as Parkinson’s disease. Medical management of these patients is very, very complex. When they’re hospitalized, sometimes their medications need to be changed. And then as they transition to the outpatient space, all of this can severely affect progression of the disease.

We’ve seen that one of the most common uses of telemedicine in the neuro space is the management of movement disorders, particularly Parkinson’s patients. So I’m really eager to see what we can do there. I’m also excited to see what we can do with telepsychiatry. I think there is significant potential.

Advertisement

Related Articles

histopathology image with pink background and arrow pointing to round cell

New Insights on α-Synuclein Pathology and Clinical Phenotypes in Dementia With Lewy Bodies

The disease’s neuropathologic heterogeneity holds clues to refining diagnosis and prognosis

MRI of the brain against black background

Advanced Neuroimaging and Clinical Perseverance Make Sense of a 68-Year-Old’s Progressive Symptoms

A case study in pairing imaging acumen with subspecialty expertise to yield answers and symptom relief

brain scan with colored dots over a dark gray region
March 3, 2026/Neurosciences/Epilepsy

Decoding the Insula: New Semiological Insights for Localizing Seizure Onset

Guidance from the largest cohort of SEEG-confirmed insular epilepsy patients reported to date

Photo of Dr. Ford
March 2, 2026/Neurosciences/Podcast

Neuroethics Conversations: Guidelines for Care (Podcast)

Ethical guidance provides guardrails so medical advances benefit patients

red blood cells floating in a blood vessel
February 27, 2026/Neurosciences/Cerebrovascular

Factor XIa Inhibition Drives Down Recurrent Stroke Risk Without Rise in Bleeding

OCEANIC-STROKE results represent long-sought advance in secondary stroke prevention

two brightly colored brain scans side by side
February 25, 2026/Neurosciences/Epilepsy

MR Fingerprinting Shows Potential to Reshape FCD Detection and Epileptogenicity Mapping

Two studies from Cleveland Clinic may help advance the technology toward broader clinical use

MRI scan of the side of a human head
February 20, 2026/Neurosciences/Cerebrovascular

Susac Syndrome: Insights on Rare Endotheliopathy From Largest Single-Center Cohort to Date

Distinct MRI signature includes lesions beyond the corpus callosum, features predictive of vision and hearing loss

Symbolic photo illustration: stethoscope on a medical dictionary

Is ‘Atypical Parkinsonism’ a Useful Term?

An argument for clarifying the nomenclature

Ad